Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackBerry
BB
|
+$2.46M |
| 2 |
BP
BP
|
+$1.73M |
| 3 |
Citigroup
C
|
+$647K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$8.36M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$4.29M |
| 3 |
HOLX
Hologic
HOLX
|
+$1.6M |
| 4 |
NTP
Nam Tai Property Inc.
NTP
|
+$610K |
| 5 |
Merck
MRK
|
+$425K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.83% |
| 2 | Financials | 25.28% |
| 3 | Energy | 12.9% |
| 4 | Communication Services | 9.29% |
| 5 | Technology | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$376B
| $59.8M | 10.83% |
1,003,975
-7,266
| -0.7% | -$425K |
|
|
2
Citigroup
C
$221B
| $51.9M | 9.4% |
1,108,395
+14,225
| +1% | +$647K |
|
|
HOLX
3
DELISTED
Hologic
HOLX
| $47.9M | 8.68% |
1,234,514
-42,470
| -3% | -$1.6M |
|
|
4
BP
BP
$115B
| $45.9M | 8.31% |
1,550,644
+59,752
| +4% | +$1.73M |
|
5
New York Times
NYT
$10.6B
| $44.7M | 8.09% |
3,738,088
-21,300
| -0.6% | -$270K |
|
|
6
BlackBerry
BB
$4.71B
| $34.7M | 6.28% |
4,343,060
+327,500
| +8% | +$2.46M |
|
7
MBIA
MBI
$250M
| $33.8M | 6.13% |
4,345,164
-10,043
| -0.2% | -$79K |
|
|
FLG
8
Flagstar Bank National Association
FLG
$5.59B
| $32.1M | 5.82% |
753,050
-97,624
| -11% | -$4.29M |
|
|
9
Pfizer
PFE
$160B
| $31.2M | 5.64% |
969,424
-249,913
| -20% | -$8.36M |
|
10
Seaboard Corp
SEB
$4.08B
| $26.9M | 4.87% |
8,679
-30
| -0.3% | -$93.3K |
|
|
NTP
11
DELISTED
Nam Tai Property Inc.
NTP
| $25.8M | 4.67% |
3,201,214
-88,197
| -3% | -$610K |
|
12
Patterson-UTI
PTEN
$4.71B
| $23.4M | 4.23% |
1,044,756
-6,625
| -0.6% | -$133K |
|
|
STL
13
DELISTED
Sterling Bancorp
STL
| $17.7M | 3.21% |
1,012,364
-2,997
| -0.3% | -$51K |
|
|
TPHS
14
DELISTED
Trinity Place Holdings Inc.com
TPHS
| $10.4M | 1.88% |
1,061,651
| – | – |
|
|
STRP
15
DELISTED
Straight Path Communications Inc.
STRP
| $5.48M | 0.99% |
213,856
-14,582
| -6% | -$349K |
|
|
VOXX
16
DELISTED
VOXX International Corporation Class A
VOXX
| $5.17M | 0.94% |
1,728,361
-13,000
| -0.7% | -$37.6K |
|
17
Navient
NAVI
$886M
| $2.68M | 0.49% |
185,091
| – | – |
|
18
Novartis
NVS
$302B
| $2.18M | 0.4% |
30,850
| – | – |
|
19
Bristol-Myers Squibb
BMY
$137B
| $1.54M | 0.28% |
28,583
| – | – |
|
20
ExxonMobil
XOM
$679B
| $1.52M | 0.28% |
17,434
| – | – |
|
21
Comcast
CMCSA
$95.3B
| $1.14M | 0.21% |
34,484
-3,936
| -10% | -$131K |
|
22
IBM
IBM
$222B
| $935K | 0.17% |
6,154
-1,542
| -20% | -$234K |
|
23
Old Republic International
ORI
$10B
| $846K | 0.15% |
48,000
-1,000
| -2% | -$19K |
|
24
Zedge
ZDGE
$38M
| $535K | 0.1% |
156,320
-1,165
| -0.7% | -$4.96K |
|
25
Chevron
CVX
$403B
| $447K | 0.08% |
4,348
-200
| -4% | -$20.4K |
|
Similar funds
Kahn Brothers's Q3 2016 Portfolio in Review
As of Q3 2016, Kahn Brothers held 37 positions worth $552M, up 6.9% from $517M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Kahn Brothers's Q3 2016 filing shows 4 increased, 23 reduced and 2 closed positions. The largest sale was Pfizer, an estimated $8.36M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Financials and Energy.
- Kahn Brothers added most to BlackBerry in Q3 2016, an estimated $2.46M increase.
- Kahn Brothers's biggest Q3 2016 reduction was Pfizer, cutting an estimated $8.36M.
- Kahn Brothers fully exited FIRST NIAGARA FINANCIAL GROUP INC in Q3 2016, selling an estimated $154K.
- Kahn Brothers's ten largest holdings make up 74% of its $552M portfolio in Q3 2016.
- Kahn Brothers opened 0 new positions and closed 2 in Q3 2016.
- Kahn Brothers's portfolio value rose 6.9% quarter-over-quarter to $552M.
Based on Kahn Brothers Group's 13F filing for Q3 2016, filed 1 Nov 2016.